[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Faster, Cleaner, Better.

Insys Therapeutics Inc (INSYQ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2013	12-2012	12-2011	12-2009	12-2008
Cash Flows From Operating Activities
Net Income	40,377	-24,378	-19,361	N/A	N/A
Depreciation Amortization	1,788	1,662	1,385	N/A	N/A
Income taxes - deferred	-12,038	N/A	N/A	N/A	N/A
Accounts receivable	-13,224	-3,089	N/A	N/A	N/A
Other Working Capital	-10,372	411	-1,345	N/A	N/A
Other Operating Activity	17,718	11,767	3,942	0	0
Operating Cash Flow	$24,249	$-13,627	$-15,379	$N/A	$N/A

Cash Flows From Investing Activities
PPE Investments	-5,125	-1,020	-599	N/A	N/A
Other Investing Activity	-400	0	0	0	0
Investing Cash Flow	$-5,525	$-1,020	$-599	$N/A	$N/A

Cash Flows From Financing Activities
Change In Short Term Borrowing	N/A	11,858	N/A	N/A	N/A
Debt Issued	N/A	2,987	15,953	N/A	N/A
Common Stock Issued	35,410	152	N/A	N/A	N/A
Common Stock Repurchased	N/A	N/A	-28	N/A	N/A
Other Financing Activity	-9,113	0	0	0	0
Financing Cash Flow	$26,297	$14,997	$15,925	$N/A	$N/A

Beginning Cash Position	361	11	64	N/A	N/A
End Cash Position	45,382	361	11	N/A	N/A
Net Cash Flow	$45,021	$350	$-53	$N/A	$N/A

Free Cash Flow
Operating Cash Flow	24,249	-13,627	-15,379	N/A	N/A
Capital Expenditure	-5,125	-1,020	-599	N/A	N/A
Free Cash Flow	19,124	-14,647	-15,978	0	0